Deerfield Private Design Fund V, L.P.
Insider CIK 1815437 · PHGE Director, 10% owner · PEPG 10% owner · BCAX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHGE BiomX Inc. | A Award deriv | 2025-04-21 | 2025-04-23 | 1,611,864 | — | $0 | 1,611,864 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-04-21 | 2025-04-23 | 1,611,864 | — | $0 | 1,611,864 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 1,258,614 | — | $0 | 1,258,614 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 1,258,614 | — | $0 | 1,258,614 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,611,863 | — | $0 | 405,637 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,611,863 | — | $0 | 405,637 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2025-02-27 | 2025-03-03 | 353,249 | $0.93 | $328.5K | 1,247,054 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2025-02-27 | 2025-03-03 | 353,249 | $0.93 | $328.5K | 1,247,054 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-17 | 2024-09-17 | 7,973,325 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-17 | 2024-09-17 | 7,973,325 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2024-09-17 | 2024-09-17 | 35,000 | $18.00 | $630.0K | 897,587 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2024-09-17 | 2024-09-17 | 35,000 | $18.00 | $630.0K | 897,587 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-17 | 2024-09-17 | 862,587 | — | $0 | 862,587 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-17 | 2024-09-17 | 862,587 | — | $0 | 862,587 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2024-07-15 | 2024-07-17 | 5,883 | — | $0 | 47,957 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2024-07-15 | 2024-07-17 | 5,883 | — | $0 | 47,957 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2024-07-15 | 2024-07-17 | 5,883,000 | — | $0 | 8,938,049 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2024-07-15 | 2024-07-17 | 5,883,000 | — | $0 | 8,938,049 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 20,175,000 | — | $0 | 20,175,000 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 20,175,000 | — | $0 | 20,175,000 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 722,175 | — | $0 | 722,175 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 722,175 | — | $0 | 722,175 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 13,490 | — | $0 | 13,490 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 40,350 | — | $0 | 53,840 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 40,350 | — | $0 | 53,840 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 13,490 | — | $0 | 13,490 | SEC↗ |
| PHGE BiomX Inc. | A Award | 2024-03-15 | 2024-03-19 | 3,055,049 | — | $0 | 3,055,049 | SEC↗ |
| PHGE BiomX Inc. | A Award | 2024-03-15 | 2024-03-19 | 3,055,049 | — | $0 | 3,055,049 | SEC↗ |
| PEPG PepGen Inc. | C Conversion deriv | 2022-05-10 | 2022-05-10 | 273,313 | — | $0 | 0 | SEC↗ |
| PEPG PepGen Inc. | C Conversion deriv | 2022-05-10 | 2022-05-10 | 273,313 | — | $0 | 0 | SEC↗ |
| PEPG PepGen Inc. | P Buy | 2022-05-10 | 2022-05-10 | 208,333 | $12.00 | $2.50M | 476,813 | SEC↗ |
| PEPG PepGen Inc. | P Buy | 2022-05-10 | 2022-05-10 | 208,333 | $12.00 | $2.50M | 476,813 | SEC↗ |
| PEPG PepGen Inc. | C Conversion | 2022-05-10 | 2022-05-10 | 268,480 | — | $0 | 268,480 | SEC↗ |
| PEPG PepGen Inc. | C Conversion | 2022-05-10 | 2022-05-10 | 268,480 | — | $0 | 268,480 | SEC↗ |